| 000 | 01634 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515105032.0 | ||
| 264 | 0 | _c20080212 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVitale, Felice Vito | |
| 245 | 0 | 0 |
_aHepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a4077-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aInfusions, Intra-Arterial |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 700 | 1 | _aRomeo, Placido | |
| 700 | 1 | _aVasta, Fabio | |
| 700 | 1 | _aPanebianco, Vincenzo | |
| 700 | 1 | _aCalì, Stefania | |
| 700 | 1 | _aRotondo, Stefano | |
| 700 | 1 | _aFerraù, Francesco | |
| 700 | 1 | _aLa Greca, Michele | |
| 773 | 0 |
_tAnticancer research _gvol. 27 _gno. 6B _gp. 4077-81 |
|
| 999 |
_c17732595 _d17732595 |
||